Methotrexate Therapy in Obstetrica? Diseases

Aneta Tomescu; Rodica  Sirbu; Stelian Paris; Emin Cadar; Cristina-Luiza Erimia; Cezar Laurentiu  Tomescu

doi:10.26417/ejis.v4i1.p9-16

Authors

Aneta Tomescu Author
Rodica Sirbu Ovidius University of Constanta, Faculty of Pharmacy, Constanta, Romania Author
Stelian Paris Ovidius University of Constanta, Faculty of Pharmacy, Constanta, Romania Author
Emin Cadar UMF Carol Davila Bucharest, Faculty of Pharmacy, Bucharest, Romania Author
Cristina-Luiza Erimia Ovidius University of Constanta, Faculty of Pharmacy, Constanta, Romania Author
Cezar Laurentiu Tomescu Ovidius University of Constanta, Faculty of Medicine, Constanta, Romania Author

DOI:

https://doi.org/10.26417/ejis.v4i1.p9-16

Keywords:

Methotrexate, obstetrics, gynecology, tubal pregnancy, HCG human chorionic gonadotrophine hormon.

Abstract

Our study is a rewiew of Methotrexate therapy in obstetrica? diseases such us: hydatidiform mole, and medical abortion. In the medical world, methotrexate is a citostatic drug used in neoplastic diseases. The clinical pharmacology data regarding methotrexate is presented, alongside route of administration and therapeutic effects in malignant disease, hydatiform mole, and medical abortion. The use of methotrexate in medical abortion and ectopic pregnancy is a great accomplishment, as it replaces a surgical intervention marred by characteristic side effects, with similar results.

Methotrexate Therapy in Obstetrica? Diseases

Authors

DOI:

Keywords:

Abstract

Downloads

Published

Issue

Section

License